Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 400,306.0 | $37.0M | 1.50% | -173K | -30.2% | $92.38 | +6.8% |
| 22 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 650,572.0 | $36.8M | 1.49% | -669K | -50.7% | $56.49 | -4.2% |
| 23 | PGNY | PROGYNY INC | Healthcare | 2,067,000.0 | $35.1M | 1.42% | NEW | — | $16.98 | +46.5% |
| 24 | INSP | INSPIRE MED SYS INC | Healthcare | 576,299.0 | $29.7M | 1.20% | +277K | +92.5% | $51.58 | -15.0% |
| 25 | EDAP | EDAP TMS S A | Healthcare | 7,309,254.0 | $27.2M | 1.10% | — | — | $3.72 | +15.6% |
| 26 | — | KINIKSA PHARMACEUTICALS INTL | — | 521,353.0 | $25.1M | 1.02% | -66K | -11.2% | $48.15 | — |
| 27 | MRK | MERCK & CO INC | Healthcare | 203,000.0 | $24.4M | 0.99% | NEW | — | $120.29 | +1.8% |
| 28 | ORGO | ORGANOGENESIS HLDGS INC | Healthcare | 10,085,951.0 | $23.9M | 0.97% | +100K | +1.0% | $2.37 | +12.2% |
| 29 | NTRA | NATERA INC | Healthcare | 119,000.0 | $23.8M | 0.96% | +99K | +495.0% | $199.99 | +1.6% |
| 30 | AXGN | AXOGEN INC | Healthcare | 679,170.0 | $22.5M | 0.91% | -528K | -43.7% | $33.13 | +23.5% |
| 31 | PCVX | VAXCYTE INC | Healthcare | 385,472.0 | $22.4M | 0.91% | -223K | -36.7% | $58.11 | -18.6% |
| 32 | ICLR | ICON PLC | Healthcare | 192,000.0 | $21.2M | 0.86% | NEW | — | $110.66 | +5.5% |
| 33 | PHVS | PHARVARIS N V | Healthcare | 702,052.0 | $19.8M | 0.80% | — | — | $28.25 | +5.1% |
| 34 | CERS | CERUS CORP | Healthcare | 10,753,700.0 | $19.6M | 0.79% | +6.8M | +168.8% | $1.82 | +48.9% |
| 35 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 1,620,000.0 | $19.3M | 0.78% | +720K | +80.0% | $11.93 | +18.4% |
| 36 | — | INHIBIKASE THERAPEUTICS INC | — | 10,875,000.0 | $18.3M | 0.74% | — | — | $1.68 | — |
| 37 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 6,963,141.0 | $18.2M | 0.74% | NEW | — | $2.62 | -0.8% |
| 38 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 2,002,000.0 | $17.9M | 0.73% | NEW | — | $8.96 | +2.6% |
| 39 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 292,000.0 | $17.0M | 0.69% | NEW | — | $58.15 | -6.8% |
| 40 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 546,000.0 | $16.2M | 0.66% | NEW | — | $29.71 | +49.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%